DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,565 filers reported holding DANAHER CORPORATION in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,560 | +3.4% | 22,410 | 0.0% | 3.35% | +9.2% |
| Q2 2023 | $5,378 | -6.5% | 22,410 | -1.8% | 3.06% | -7.0% |
| Q1 2023 | $5,749 | -9.1% | 22,810 | -4.3% | 3.29% | -9.5% |
| Q4 2022 | $6,326 | -99.9% | 23,835 | -0.5% | 3.64% | -6.2% |
| Q3 2022 | $6,186,000 | +3.0% | 23,950 | +1.1% | 3.88% | +10.4% |
| Q2 2022 | $6,008,000 | -13.8% | 23,700 | -0.2% | 3.52% | +3.4% |
| Q1 2022 | $6,967,000 | -15.2% | 23,750 | -4.9% | 3.40% | -12.5% |
| Q4 2021 | $8,220,000 | +9.5% | 24,985 | +1.3% | 3.89% | +0.8% |
| Q3 2021 | $7,510,000 | +15.4% | 24,668 | +1.7% | 3.86% | +14.0% |
| Q2 2021 | $6,510,000 | +18.9% | 24,258 | -0.2% | 3.38% | +11.4% |
| Q1 2021 | $5,473,000 | -2.0% | 24,318 | -3.3% | 3.04% | -11.6% |
| Q4 2020 | $5,585,000 | +1.8% | 25,143 | -1.3% | 3.43% | -10.0% |
| Q3 2020 | $5,487,000 | +20.4% | 25,483 | -1.1% | 3.81% | +15.2% |
| Q2 2020 | $4,558,000 | +26.4% | 25,778 | -1.1% | 3.31% | +8.5% |
| Q1 2020 | $3,607,000 | -13.3% | 26,058 | -3.8% | 3.05% | +10.7% |
| Q4 2019 | $4,159,000 | +6.2% | 27,098 | -0.1% | 2.76% | -3.6% |
| Q3 2019 | $3,918,000 | -22.2% | 27,128 | -23.1% | 2.86% | -20.6% |
| Q2 2019 | $5,039,000 | +7.9% | 35,256 | -0.4% | 3.60% | +4.8% |
| Q1 2019 | $4,672,000 | +23.7% | 35,386 | -3.4% | 3.44% | +11.7% |
| Q4 2018 | $3,778,000 | -5.6% | 36,636 | -0.6% | 3.08% | +12.6% |
| Q3 2018 | $4,004,000 | +8.9% | 36,848 | -1.1% | 2.73% | +1.1% |
| Q2 2018 | $3,676,000 | -1.7% | 37,248 | -2.5% | 2.70% | +1.1% |
| Q1 2018 | $3,740,000 | +3.1% | 38,203 | -2.3% | 2.68% | +6.7% |
| Q4 2017 | $3,628,000 | +6.1% | 39,086 | -1.9% | 2.51% | +4.3% |
| Q3 2017 | $3,418,000 | +0.4% | 39,841 | -1.3% | 2.40% | +8.9% |
| Q2 2017 | $3,406,000 | -2.1% | 40,356 | -0.8% | 2.21% | -12.4% |
| Q1 2017 | $3,478,000 | +6.9% | 40,661 | -2.8% | 2.52% | +8.7% |
| Q4 2016 | $3,255,000 | -1.4% | 41,811 | -0.7% | 2.32% | +4.8% |
| Q3 2016 | $3,300,000 | -22.8% | 42,099 | -0.5% | 2.21% | -25.2% |
| Q2 2016 | $4,273,000 | +3.7% | 42,311 | -2.6% | 2.95% | -8.9% |
| Q1 2016 | $4,120,000 | +1.4% | 43,428 | -0.7% | 3.24% | -1.6% |
| Q4 2015 | $4,063,000 | +8.3% | 43,743 | -0.6% | 3.29% | +5.8% |
| Q3 2015 | $3,751,000 | -3.2% | 44,018 | -2.8% | 3.11% | +11.9% |
| Q2 2015 | $3,875,000 | -2.5% | 45,278 | -3.3% | 2.78% | +1.5% |
| Q1 2015 | $3,976,000 | – | 46,830 | – | 2.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |